44 results
424B3
BTTX
Better Therapeutics Inc
10 Jan 24
Prospectus supplement
7:01am
. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company
8-K
EX-10.1
BTTX
Better Therapeutics Inc
8 Jan 24
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
4:42pm
Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company
424B3
BTTX
Better Therapeutics Inc
28 Dec 23
Prospectus supplement
9:23pm
of the right to affix the CE mark in the European Union. The actual timing of these milestones could vary dramatically compared to our estimates … product pricing vary widely from country to country. For example, the European Union provides options for its Member States to restrict the range
8-K
EX-10.1
s1ip45sy3v
13 Dec 23
Entry into a Material Definitive Agreement
5:06pm
8-K
EX-99.1
9a6vxbt
9 Nov 23
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:03am
8-K
EX-10.2
js03bnl na
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
8-K
EX-10.1
bjpjyevrv2w2v0w sv90
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
8-K
EX-10.1
5xs3aw55k97dp
11 May 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-10.1
960mrfr
7 Apr 23
Better Therapeutics Announces $6.5MM Private Placement
4:52pm